Tax-driven sale by Alignment Healthcare (ALHC) president after RSU vesting

Rhea-AI Filing Summary

Alignment Healthcare, Inc. president Dawn Christine Maroney reported selling a total of 29,113 shares of common stock on March 12, 2026 in open-market transactions. Footnotes state these shares were sold solely to cover tax withholding obligations tied to vesting restricted stock units and were not discretionary trades. After these sales, she continues to hold 963,702 shares of Alignment Healthcare common stock directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maroney Dawn Christine

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/12/2026		S		27,350(1)	D	$17.476(2)	965,465	D
Common Stock	03/12/2026		S		1,763(1)	D	$16.9919(3)	963,702	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.035 to $18.03. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

3. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.92 to $17.03. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Alignment Healthcare (ALHC) president Dawn Maroney report?

Dawn Christine Maroney reported selling 29,113 shares of Alignment Healthcare common stock. The sales occurred on March 12, 2026 and were disclosed as open-market transactions on a Form 4 insider filing with the Securities and Exchange Commission.

How many Alignment Healthcare (ALHC) shares did Dawn Maroney sell and at what prices?

She sold 27,350 shares at a weighted-average price of $17.476 and 1,763 shares at a weighted-average price of $16.9919. Footnotes note sales occurred across multiple trades within stated price ranges around those averages.

Why did Dawn Maroney sell Alignment Healthcare (ALHC) shares in this Form 4 filing?

The filing explains the 29,113 shares sold were required to cover tax withholding obligations from vesting restricted stock units. It explicitly states the transactions do not represent discretionary trades by the reporting person, indicating a tax-related, mechanical sale.

How many Alignment Healthcare (ALHC) shares does Dawn Maroney still own after the sale?

After the reported transactions, Dawn Christine Maroney directly holds 963,702 shares of Alignment Healthcare common stock. This post-transaction holding is disclosed in the Form 4 as the total number of shares owned following the March 12, 2026 sales.

Were any options or derivative securities exercised in Dawn Maroney’s latest ALHC Form 4?

No derivative transactions are listed in the filing’s derivative summary. The reported activity involves only non-derivative common stock sales associated with tax withholding on restricted stock unit vesting, with no option exercises or other derivative conversions disclosed.

Were Dawn Maroney’s Alignment Healthcare (ALHC) share sales discretionary market trades?

The footnotes clarify the sales represent shares required to be sold to satisfy tax withholding obligations upon RSU vesting. The language states the transaction does not represent a discretionary trade by the reporting person, characterizing it as a tax-driven, automatic sale.